430 related articles for article (PubMed ID: 33309278)
1. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER).
Valle LF; Lehrer EJ; Markovic D; Elashoff D; Levin-Epstein R; Karnes RJ; Reiter RE; Rettig M; Calais J; Nickols NG; Dess RT; Spratt DE; Steinberg ML; Nguyen PL; Davis BJ; Zaorsky NG; Kishan AU
Eur Urol; 2021 Sep; 80(3):280-292. PubMed ID: 33309278
[TBL] [Abstract][Full Text] [Related]
2. Nonsurgical salvage options for locally recurrent prostate cancer after primary definitive radiotherapy: a systematic review and meta-analysis.
Yang J; Xiong X; Liao X; Zheng W; Xu H; Wei Q; Yang L
Int J Surg; 2024 May; 110(5):3008-3020. PubMed ID: 38348896
[TBL] [Abstract][Full Text] [Related]
3. Local salvage of radiorecurrent prostate cancer.
Henderson RH; Bryant C; Nichols RC; Mendenhall WM; Mendenhall NP
Prostate; 2023 Aug; 83(11):1001-1010. PubMed ID: 37150849
[TBL] [Abstract][Full Text] [Related]
4. Focal versus whole gland salvage brachytherapy for recurrent prostate cancer in the prostate specific membrane antigen PET era: a narrative review.
Andring LM; Teh BS; Butler EB; Farach AM
Chin Clin Oncol; 2023 Jun; 12(3):26. PubMed ID: 37417290
[TBL] [Abstract][Full Text] [Related]
5. F-SHARP: a Phase I/II trial of focal salvage high-dose-rate brachytherapy for Radiorecurrent prostate cancer.
Solanki AA; Yoo RK; Adams W; Davicioni E; Mysz ML; Shea S; Gupta GN; Showalter T; Garant A; Hentz C; Farooq A; Baldea K; Small W; Harkenrider MM
BJU Int; 2024 Feb; 133(2):188-196. PubMed ID: 37562825
[TBL] [Abstract][Full Text] [Related]
6. Salvage Reirradiation Options for Locally Recurrent Prostate Cancer: A Systematic Review.
Zhong J; Slevin F; Scarsbrook AF; Serra M; Choudhury A; Hoskin PJ; Brown S; Henry AM
Front Oncol; 2021; 11():681448. PubMed ID: 34568012
[TBL] [Abstract][Full Text] [Related]
7. Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time.
Kollmeier MA; McBride S; Taggar A; Anderson E; Lin M; Pei X; Weiji S; Voros L; Cohen G; Yamada Y; Zelefsky MJ
Brachytherapy; 2017; 16(6):1091-1098. PubMed ID: 28838648
[TBL] [Abstract][Full Text] [Related]
8. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
[TBL] [Abstract][Full Text] [Related]
9. Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy.
Henríquez López I; González-San Segundo C; Vegas JO; Gutierrez C; Hervas A; Cabeza Rodriguez MÁ; Valero Albarrán J; Rodríguez Villalba S; Álvarez Gonzalez A; Sancho Pardo G; Zapatero A; Álvaro PC
Radiother Oncol; 2019 Dec; 141():156-163. PubMed ID: 31570236
[TBL] [Abstract][Full Text] [Related]
10. Salvage high-intensity focused ultrasound versus salvage radical prostatectomy for radiation-recurrent prostate cancer: a comparative study of oncological, functional, and toxicity outcomes.
Devos B; Al Hajj Obeid W; Andrianne C; Diamand R; Peltier A; Everaerts W; Van Poppel H; Van Velthoven R; Joniau S
World J Urol; 2019 Aug; 37(8):1507-1515. PubMed ID: 30666400
[TBL] [Abstract][Full Text] [Related]
11. Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT).
Zhong J; Brown S; Serra M; Shuttleworth P; Bownes P; Thompson C; Reed R; Reeves K; Dubec M; McHugh D; Eccles C; Chuter R; Tsang YM; Taylor NJ; West C; Buckley D; Scarsbrook A; Choudhury A; Hoskin P; Henry A
BMJ Open; 2022 Nov; 12(11):e068580. PubMed ID: 36351720
[TBL] [Abstract][Full Text] [Related]
12. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT
Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626
[TBL] [Abstract][Full Text] [Related]
13. Salvage Therapy Options for Local Prostate Cancer Recurrence After Primary Radiotherapy: a Literature Review.
Golbari NM; Katz AE
Curr Urol Rep; 2017 Aug; 18(8):63. PubMed ID: 28688020
[TBL] [Abstract][Full Text] [Related]
14. Impact of High-Dose-Rate and Low-Dose-Rate Brachytherapy Boost on Toxicity, Functional and Cancer Outcomes in Patients Receiving External Beam Radiation Therapy for Prostate Cancer: A National Population-Based Study.
Parry MG; Nossiter J; Sujenthiran A; Cowling TE; Patel RN; Morris M; Berry B; Cathcart P; Clarke NW; Payne H; van der Meulen J; Aggarwal A
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1219-1229. PubMed ID: 33279595
[TBL] [Abstract][Full Text] [Related]
15. Salvage reirradiation for local prostate cancer recurrence after radiation therapy. For who? When? How?
Baty M; Créhange G; Pasquier D; Palard X; Deleuze A; Gnep K; Key S; Beuzit L; Castelli J; de Crevoisier R
Cancer Radiother; 2019 Oct; 23(6-7):541-558. PubMed ID: 31421999
[TBL] [Abstract][Full Text] [Related]
16. A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy.
Yamada Y; Kollmeier MA; Pei X; Kan CC; Cohen GN; Donat SM; Cox BW; Zelefsky MJ
Brachytherapy; 2014; 13(2):111-6. PubMed ID: 24373762
[TBL] [Abstract][Full Text] [Related]
17. Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study.
Archer P; Marvaso G; Detti B; Colombo F; Francolini G; Vandendorpe B; Thananayagam MA; Baty M; De Crevoisier R; Alongi F; Nicosia L; Scher N; Toledano A; Di Muzio N; Fodor A; Zilli T; Franzese C; Scorsetti M; Shelan M; Triggiani L; Aymes E; Le Deley MC; Jereczek-Fossa BA; Pasquier D
Eur Urol Oncol; 2023 Jun; 6(3):303-310. PubMed ID: 37012102
[TBL] [Abstract][Full Text] [Related]
18. Management of local relapse after prostate cancer radiotherapy: Surgery or radiotherapy?
Hennequin C; Hannoun-Lévi JM; Rozet F
Cancer Radiother; 2017 Oct; 21(6-7):433-436. PubMed ID: 28890088
[TBL] [Abstract][Full Text] [Related]
19. Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer.
Boehm K; Schiffmann J; Tian Z; Lesmana H; Larcher A; Mandel P; Karakiewicz PI; Graefen M; Schwarz R; Krüll A; Tilki D
Urol Oncol; 2016 Mar; 34(3):119.e11-8. PubMed ID: 26602027
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of salvage high dose-rate brachytherapy with or without pelvic external beam radiotherapy in patients with palpable local recurrence of prostate cancer after radical prostatectomy.
Ni L; Chen K; Phuong C; Sabbagh AR; Wong AC; Mohamad O; Hsu IC
Brachytherapy; 2023; 22(3):304-309. PubMed ID: 36623988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
